Creso Pharma
Creso Pharma
(ASX:CPH, FWB:1X8)


 

  Our Initial Entry
Price

Portfolio Initiation

5 Day VWAP
After Initiation

Current Price

Our Current Returns

ASX:CPH
$0.120
$0.000
Jan 01 2021
$0.000
$0.185
    54%

ASX:CPH
Our Current Returns
54%
View


Overview

📋 About: Creso Pharma (ASX: CPH) is Medical cannabis and psychedelics company, developing therapeutic, nutraceutical and lifestyle products for human and animal health.

🌏 Macro Theme: World regulations are expected to open up as cannabis and psychedlics become an accepted form of alternative medicine.

Creso Pharma Company Milestones

✅ $9M Cap Raise @ 2.9c: Next Investors Commentary
✅ Convertible Notes Extinguished:
Next Investors Commentary
✅ Key Appointment: Bruce Linton:
Next Investors Commentary
✅ Next Investors Watchlist:
Next Investors Commentary
🌏 TGA Reclassifies Cannabis as a Schedule 4 drug:
Next Investors Commentary
🌏 MORE Act Passed in the US:
Next Investors Commentary
✅ $18M Cap Raise @19c per share:
Next Investors Commentary
🌏 MindMed NASDAQ Listing:
Next Investors Commentary 1, Next Investors Commentary 2
✅ OTC Listing

🔲 Improved Global Regulatory Environment for Cannabis
🔲 Improved Global Regulatory Environment for Psychedelics
🔲 Unexpected Positive Announcement 1
🔲 Unexpected Positive Announcement 2
🔲 Unexpected Positive Announcement 3
🔲 Next Investors Portfolio Launch?

Cannabis Products

Purchase orders listed here are over $150k only

✅ Purchase Order 1 $295K (Nutraceutical / Pharma Products)
✅ Purchase Order(s) 2 $415K + (Nutraceutical / Pharma Products):
Next Investors Commentary
✅ Purchase Order 3 $300K + (Nutraceutical / Pharma Products)
✅ Purchase Order 4 $247K + (Nutraceutical / Pharma Products):
Next Investors Commentary
🔲 Purchase Order 5 (Nutraceutical / Pharma Products)
🔲 Purchase Order 6 (Nutraceutical / Pharma Products)
🔲 Purchase Order 7 (Nutraceutical / Pharma Products)
🔲 Purchase Order 8 (Nutraceutical / Pharma Products)
✅ Purchase Order 1 $242K+ (Mernova Cannabis)
✅ Purchase Order(s) 2 $502K+ (Mernova Cannabis):
Next Investors Commentary
✅ Purchase Order 3 $177K+ (Mernova Cannabis)

🔲 Purchase Order 4 (Mernova Cannabis)
🔲 Purchase Order 5 (Mernova Cannabis)
🔲 Purchase Order 6 (Mernova Cannabis)
🔲 Purchase Order 7 (Mernova Cannabis)
🔲 Purchase Order 8 (Mernova Cannabis)

Psychedelics

✅ Plan to acquire Halucenex (psychedlics company) announced: Next Investors Commentary
✅ Increase Psilocybin Supply for Clinical Trials:
Next Investors Commentary
🔲 Halucenex receives Dealers License
🔲 Complete Halucenex Acquisition
🔲 Phase II Clinical Trials recruitment
🔲 Phase II Clinical Trials begin
🔲 Phase II Clinical Trials - interim results
🔲 Phase II Clinical Trial Completed
🔲 Phase II Clinical Trial Results
🔲 Commercialisation milestone

Investment Plan

ASX:CPH is a medium term investment we hold and write about that is not currently in the portfolio. We took a position at 3c in October 2020 as a short term hold which upgraded to a medium hold after the company delivered. On March 26 2021 we increased our position at 19c. We are considering adding CPH to our long term portfolio if it can deliver a few more key milestones.

✅ Initial Investment @ 3c
✅ Increased Investment 19c

🔲 Increased Investment
✅ Price Increase 500% from Initial Entry
✅ Price Increase 1,000% from Initial Entry

🔲 Price Increase 2,000% from Initial Entry
🔲 12 Month Capital Gains Discount
✅ Free Carry
✅ Take Profits

🔲 Hold Remaining Position for Two Years



Our Past Commentary on Creso Pharma


Type Date Share Price $ Title
Email 11-Jun-2021 $ 0.165 CPH’s US listing is happening tonight - trading as OTC: COPHF
Email 05-Jun-2021 $ 0.165 So What Happened this Week?
Email 14-May-2021 $ 0.180 CPH just picked up 10 grams of pharma grade psilocybin
Email 28-Apr-2021 $ 0.210 Zero Carbon Ammonia? What happened last night?
Email 27-Apr-2021 $ 0.195 The NASDAQ Listing We Will be Watching Tonight
Email 27-Apr-2021 $ 0.195 Our Portfolio Performance from January 1st to March 31st 2020
Email 26-Mar-2021 $ 0.205 We Participated in the CPH placement - and so did Billionaire John Hancock
Email 23-Mar-2021 $ 0.220 TRIPLE DOWN ALERT - Plus 6 Hot Stocks
Email 15-Mar-2021 $ 0.220 SURPRISE: We are Now Psychedelics Investors
Article 15-Mar-2021 $ 0.220 CPH to be the First ASX Stock to Acquire 100% of a Psychedelics Company
Email 01-Mar-2021 $ 0.205 CPH deliver Financials and Confirms US Cannabis Market Entry
Article 01-Mar-2021 $ 0.205 CPH Confirms US Cannabis Market Entry with Established Partner - US$5M Sales Target
Email 19-Jan-2021 $ 0.240 The CPH Share Price Seems to Have Stabilised – What’s Next?
Article 07-Jan-2021 $ 0.195 Our Stock Picks for 2021
Article 02-Dec-2020 $ 0.046 What’s Happening to the CPH Share Price?
Email 02-Dec-2020 $ 0.046 Short Term Trade Update: What’s Happening to the CPH Share Price?
Article 13-Oct-2020 $ 0.031 Canopy Growth Founder Joins a Refreshed, Re-Set and Re-Funded CPH
Email 13-Oct-2020 $ 0.035 We are Rolling the Dice on this One…
Article 24-Mar-2020 $ 0.053 Creso’s New Immunity Boosting CBD Hemp Teas Set for Release
Article 11-Mar-2020 $ 0.071 CPH Secures Two Execs from the World’s Largest Cannabis Company
Article 04-Mar-2020 $ 0.082 Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint
Article 11-Feb-2020 $ 0.160 Creso on a Roll: New Hemp Plant Product for Equines and Large Animals Set for Release
Article 06-Feb-2020 $ 0.155 CPH Set to Expand cannaQIX® Product Line After Major Technological Breakthrough
Article 28-Jan-2020 $ 0.175 CPH’s cannaQIX® Products Have Now Exceeded the 2.5 million Lozenges Sold Milestone
Article 21-Jan-2020 $ 0.190 CPH Delivers Over 3 Million Anibidiol Doses to Europe's Dogs
Article 09-Dec-2019 $ 0.145 CPH Kick Start African Launch - $300k Order Values Confirmed
Article 03-Dec-2019 $ 0.150 Can New Cannabis Products Launch Creso Pharma Higher in 2020?


Market Data


Latest Article

CPH’s US listing is happening tonight - trading as OTC: COPHF

CPH’s US listing is happening tonight - trading as OTC: COPHF

Creso Pharma (ASX:CPH) today announced its listing in the US, and the market is opening in around 12 hours - the US pool of investors is huge and they have a big appetite for psychedelics and cannabis stocks.

Related Articles

So What Happened this Week?

So What Happened this Week?

CPH just picked up 10 grams of pharma grade psilocybin

CPH just picked up 10 grams of pharma grade psilocybin

Zero Carbon Ammonia? What happened last night?

Zero Carbon Ammonia? What happened last night?

The NASDAQ Listing We Will be Watching Tonight

The NASDAQ Listing We Will be Watching Tonight

Our Portfolio Performance from January 1st to March 31st 2020

Our Portfolio Performance from January 1st to March 31st 2020

We Participated in the CPH placement - and so did Billionaire John Hancock

We Participated in the CPH placement - and so did Billionaire John Hancock

TRIPLE DOWN ALERT - Plus 6 Hot Stocks

TRIPLE DOWN ALERT - Plus 6 Hot Stocks

SURPRISE: We are Now Psychedelics Investors

SURPRISE: We are Now Psychedelics Investors

CPH to be the First ASX Stock to Acquire 100% of a Psychedelics Company

CPH to be the First ASX Stock to Acquire 100% of a Psychedelics Company

CPH deliver Financials and Confirms US Cannabis Market Entry

CPH deliver Financials and Confirms US Cannabis Market Entry

CPH Confirms US Cannabis Market Entry with Established Partner - US$5M Sales Target

CPH Confirms US Cannabis Market Entry with Established Partner - US$5M Sales Target

The CPH Share Price Seems to Have Stabilised – What’s Next?

The CPH Share Price Seems to Have Stabilised – What’s Next?

Our Stock Picks for 2021

Our Stock Picks for 2021

What’s Happening to the CPH Share Price?

What’s Happening to the CPH Share Price?

Short Term Trade Update: What’s Happening to the CPH Share Price?

Short Term Trade Update: What’s Happening to the CPH Share Price?

Canopy Growth Founder Joins a Refreshed, Re-Set and Re-Funded CPH

Canopy Growth Founder Joins a Refreshed, Re-Set and Re-Funded CPH

We are Rolling the Dice on this One…

We are Rolling the Dice on this One…

Creso’s New Immunity Boosting CBD Hemp Teas Set for Release

Creso’s New Immunity Boosting CBD Hemp Teas Set for Release

CPH Secures Two Execs from the World’s Largest Cannabis Company

CPH Secures Two Execs from the World’s Largest Cannabis Company

Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint

Scandinavian Sales Agreement Expands Creso Pharma’s European Footprint

Creso on a Roll: New Hemp Plant Product for Equines and Large Animals Set for Release

Creso on a Roll: New Hemp Plant Product for Equines and Large Animals Set for Release

CPH Set to Expand cannaQIX® Product Line After Major Technological Breakthrough

CPH Set to Expand cannaQIX® Product Line After Major Technological Breakthrough

CPH’s cannaQIX® Products Have Now Exceeded the 2.5 million Lozenges Sold Milestone

CPH’s cannaQIX® Products Have Now Exceeded the 2.5 million Lozenges Sold Milestone

CPH Delivers Over 3 Million Anibidiol Doses to Europe's Dogs

CPH Delivers Over 3 Million Anibidiol Doses to Europe's Dogs

CPH Kick Start African Launch - $300k Order Values Confirmed

CPH Kick Start African Launch - $300k Order Values Confirmed

Can New Cannabis Products Launch Creso Pharma Higher in 2020?

Can New Cannabis Products Launch Creso Pharma Higher in 2020?

Thanks for subscribing!

X